HIV News and Research

RSS

HIV/AIDS experts awarded over $5M to foster health and medical research skills in India, Africa

Experts in HIV/AIDS at the Johns Hopkins University's School of Medicine and the university's Bloomberg School of Public Health have been awarded more than $5 million by the Fogarty International Center's HIV Research Training Program to foster health and medical research skills in India, Uganda, Ethiopia and Malawi.

13 Nov 2013

Furamidine drug may also be useful in treating cancers, immune-related diseases

A class of drugs used to treat parasitic infections such as malaria may also be useful in treating cancers and immune-related diseases, a new WSU-led study has found.

12 Nov 2013

European Medicines Agency awards orphan drug designation to NanoViricides' DengueCide

NanoViricides, Inc. announced today that the European Medicines Agency, has awarded orphan drug designation to DengueCide, the Company's drug candidate for the treatment of dengue and dengue hemorrhagic fever.

11 Nov 2013

Mylan Pharmaceuticals launches Rabeprazole Sodium Delayed-release Tablets

Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Rabeprazole Sodium Delayed-release Tablets, 20 mg.

11 Nov 2013

Research roundup: Pricing and the SHOP exchange; health use in rural vs. urban areas; the health law and AIDS care

Each week, KHN compiles a selection of recently released health policy studies and briefs.

11 Nov 2013

Researchers launch clinical trial of investigational vaccine designed to prevent genital herpes disease

Researchers have launched an early-stage clinical trial of an investigational vaccine designed to prevent genital herpes disease. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring the Phase I trial, which is being conducted at the NIH Clinical Center in Bethesda, Md.

11 Nov 2013

Gladstone-led study sheds light on critical molecular process

One of biology's most fundamental processes is something called transcription. It is just one step of many required to build proteins-and without it life would not exist. However, many aspects of transcription remain shrouded in mystery. But now, scientists at the Gladstone Institutes are shedding light on key aspects of transcription, and in so doing are coming even closer to understanding the importance of this process in the growth and development of cells-as well as what happens when this process goes awry.

8 Nov 2013

Clinical testing expanded for vaccine against latent TB

Statens Serum Institut and Aeras today announced the initiation of a Phase I/IIa clinical trial for a candidate tuberculosis vaccine designed to protect people, especially those latently infected with TB, from developing active TB disease.

8 Nov 2013

New hand-held device can help prevent thousands of unnecessary TB deaths

Thousands of deaths from tuberculosis, an infectious bacterial disease, could be prevented using a new hand-held device that is being developed to detect potentially fatal drug resistance in less than 15 minutes.

7 Nov 2013

Diagnostic technology advancing but barriers prevent integration into care, IDSA report warns

Despite advances in diagnostic technology, there is an urgent need for tests that are easy to use, identify the bug causing an infection and provide results faster than current tests, according to a report from the Infectious Diseases Society of America published today in a special supplement to Clinical Infectious Diseases.

7 Nov 2013

Researchers, clinicians discuss recent findings that could bring hope for people with HIV

Since the onset of the AIDS pandemic more than three decades ago, researchers from the lab and physicians in the clinic have been working toward one shared goal: an AIDS-free world. This week, a conference hosted by the journals Cell and The Lancet brought leading researchers and clinicians together to discuss recent findings that could bring hope to the estimated 35 million people world-wide who live with HIV.

7 Nov 2013

New 4th generation HIV assays now available to improve screening for HIV infection

Laboratory Corporation of America Holdings announced today the availability of a 4th generation HIV antigen/antibody combination assay and a new diagnostic algorithm that improves screening for HIV infection.

6 Nov 2013

Finding challenges assumption that bisexual men responsible for HIV transmission to female partners

The number of HIV positive men who have sex with both men and women is likely no higher than the number of HIV positive heterosexual men, according to a U.S.-based analysis by University of Pittsburgh Graduate School of Public Health researchers.

6 Nov 2013

Bisexual men, women face prejudice and discrimination from both heterosexual, homosexual people

Men who identify themselves as heterosexual are three times more likely to categorize bisexuality as "not a legitimate sexual orientation," an attitude that can encourage negative health outcomes in people who identify as bisexual, according to an analysis led by University of Pittsburgh Graduate School of Public Health researcher Mackey Friedman, Ph.D., M.P.H.

5 Nov 2013

Pivotal Phase III STARTVerso data shows efficacy of faldaprevir in genotype-1 infected HCV patients

Boehringer Ingelheim today announced new data from its Phase III clinical trial programme, STARTVerso, which evaluates faldaprevir in combination with pegylated interferon and ribavirin (PegIFN/RBV).

5 Nov 2013

EVIDENCE project responds to critical challenges for scaling up quality family planning, reproductive health programs

The Population Council has been granted a cooperative agreement from the US Agency for International Development's (USAID) Office of Population and Reproductive Health (PRH).

5 Nov 2013

Two organochlorine pesticides associated with increased risk of endometriosis

A Fred Hutchinson Cancer Research Center-led study has found that two organochlorine pesticides are associated with an increased risk of endometriosis, a condition that affects up to 10 percent of reproductive-age women.

5 Nov 2013

Boehringer Ingelheim's Phase II trial of interferon-free hepatitis C treatment shows promising results

Interim data presented today show that all patients (13/13) who reached their 4-week post-treatment follow-up have undetectable levels of hepatitis C virus (SVR4) after completing a 12-week regimen of faldaprevir, deleobuvir, PPI-668 and ribavirin.

4 Nov 2013

Stop L.A. Corruption: A new awareness campaign that highlights failures of LA County

Health and public policy advocates from AIDS Healthcare Foundation (AHF) will unveil 'Stop L.A. Corruption,' a new advocacy and awareness campaign highlighting the profound failures of Los Angeles County and its key elected and appointed officials in carrying out their sworn duties to serve and protect the nearly 10 million residents of the County.

4 Nov 2013

VG Life Sciences' peptide awarded US patent for HIV treatment

The United States Patent and Trademark Office has issued on October 15, 2013 Patent No.: US 8,557,764 covering the VG Life Sciences' peptide VG1177 for treating HIV infection.

31 Oct 2013

HIV News and Research

HIV/AIDS experts awarded over $5M to foster health and medical research skills in India, Africa

Furamidine drug may also be useful in treating cancers, immune-related diseases

European Medicines Agency awards orphan drug designation to NanoViricides' DengueCide

Mylan Pharmaceuticals launches Rabeprazole Sodium Delayed-release Tablets

Research roundup: Pricing and the SHOP exchange; health use in rural vs. urban areas; the health law and AIDS care

Researchers launch clinical trial of investigational vaccine designed to prevent genital herpes disease

Gladstone-led study sheds light on critical molecular process

Clinical testing expanded for vaccine against latent TB

New hand-held device can help prevent thousands of unnecessary TB deaths

Diagnostic technology advancing but barriers prevent integration into care, IDSA report warns

Researchers, clinicians discuss recent findings that could bring hope for people with HIV

New 4th generation HIV assays now available to improve screening for HIV infection

Finding challenges assumption that bisexual men responsible for HIV transmission to female partners

Bisexual men, women face prejudice and discrimination from both heterosexual, homosexual people

Pivotal Phase III STARTVerso data shows efficacy of faldaprevir in genotype-1 infected HCV patients

EVIDENCE project responds to critical challenges for scaling up quality family planning, reproductive health programs

Two organochlorine pesticides associated with increased risk of endometriosis

Boehringer Ingelheim's Phase II trial of interferon-free hepatitis C treatment shows promising results

Stop L.A. Corruption: A new awareness campaign that highlights failures of LA County

VG Life Sciences' peptide awarded US patent for HIV treatment

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News